Insider Transactions in Q3 2022 at Apyx Medical Corp (APYX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2022
|
Charles D. Goodwin Ii Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
11,750
+12.9%
|
$58,750
$5.95 P/Share
|
|
Jul 11
2022
|
Moshe Citronowicz Sr. V.P. of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.17%
|
$60,000
$2.54 P/Share
|
|
Jul 11
2022
|
Lawrence Waldman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+38.98%
|
$48,000
$2.54 P/Share
|
|
Jul 06
2022
|
Michael Geraghty Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.6%
|
$8,000
$2.54 P/Share
|
|
Jul 05
2022
|
Andrew Makrides Director |
SELL
Payment of exercise price or tax liability
|
Direct |
13,583
-2.13%
|
$81,498
$6.14 P/Share
|
|
Jul 05
2022
|
Andrew Makrides Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.49%
|
$60,000
$2.54 P/Share
|